Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

AGM Results

30 May 2012 11:36

RNS Number : 4067E
Microsaic Systems plc
30 May 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

AGM Results, Completion of Placing, Board and Committee Changes

 

30 May 2012

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, announces that its Annual General Meeting ("AGM") was held at 11.00 a.m. (UK time) this morning and that all resolutions were duly passed.

 

Following the announcement on 29 May and the passing of the resolutions at the AGM, the Company is also pleased to announce that the conditional placing ("Placing") of 3,867,248 new ordinary shares of 0.25p each ("Placing Shares") at a price of 40 pence per Placing Share, raising approximately £1.55 million (before expenses), has been completed subject to admission of the Placing Shares (expected on 1 June 2012) becoming effective in accordance with the AIM Rules for Companies. The net proceeds of the Placing will be deployed to further the growth plans of the Company.

 

Non-executive director Peter Selway formally retired from Microsaic's board of directors at the AGM. Mr Selway's intention to retire during the current financial year was noted in the Company's preliminary results for the full year ending 31 December 2012.

 

As a result of Mr Selway's retirement, non-executive director Andrew Holmes has been appointed to the audit and remuneration committees of the Company's board of directors. The audit committee is chaired by Colin Nicholl and also comprises James Ramage and Andrew Holmes. The remuneration committee is now chaired by James Ramage and also comprises Colin Nicholl and Andrew Holmes.

 

Colin Nicholl, commented:

 

"Peter has planned for some time to retire upon reaching the age of 70 in 2012. The board is most grateful for his wise council and distinguished service over the last 11 years, and we all wish him well and a long and happy retirement."

 

Enquiries:

 

Microsaic Systems plc

via Citigate Dewe Rogerson

Eric Yeatman, CEO

Colin Nicholl, Chairman

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7638 9571

Chris Gardner, Mark Swallow, Malcolm Robertson

The Scott Partnership (Trade PR)

+44 (0)1477 539540

Sarah Evans

 

 

About Microsaic Systems plc

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMWGUAWAUPPGUU
Date   Source Headline
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSInvestor Event
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.